Studies in COVID-19

Adaptive COVID-19 Treatment Trial in the EU & UK (ACTT-EU/UK) - A Multicenter, Adaptive, Randomised Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalised Adults

A collaborative initiative to describe the neurological features of COVID-19

A first-in-human clinical trial to assess the safety and immunogenicity of a self-amplifying ribonucleic acid (saRNA) vaccine encoding the S glycoprotein of SARS-CoV-2, the causative agent of COVID 19

An International Observational Study of Outpatients with SARS-CoV-2 Infection

An International Multicenter, Adaptive, Randomized Double-Blind, Placebo-Controlled Trial of the Safety, Tolerability and Efficacy of Anti-Coronavirus Hyperimmune Intravenous Immunoglobulin for the Treatment of Adult Hospitalized Patients at Onset of Clinical Progression of COVID-19

Outpatient Treatment with Anti-Coronavirus Immunoglobulin in people at higher risk for severe COVID-19

Does giving patients hospitalised with COVID-19 a synthetically made antibody that blocks the virus make them get better more quickly?

SARS-CoV2 Variants Evaluation in Pregnancy and Paediatrics Cohorts